July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
X-Chromosome Inactivation is a Biomarker of Clinical Severity in Female Carriers of X-linked Retinitis Pigmentosa
Author Affiliations & Notes
  • Abigail T Fahim
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • Lori S Sullivan
    Genetics, University of Texas Health Science Center, Houston, Texas, United States
  • Sara J Bowne
    Genetics, University of Texas Health Science Center, Houston, Texas, United States
  • Kaylie Webb-Jones
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Dianna K.H. Wheaton
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Kari E Branham
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • Mohammad Othman
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • Athanasios J Karoukis
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • Chris Andrews
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • John R Heckenlively
    Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, United States
  • David G Birch
    Retina Foundation of the Southwest, Dallas, Texas, United States
  • Stephen P Daiger
    Genetics, University of Texas Health Science Center, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Abigail Fahim, None; Lori Sullivan, None; Sara Bowne, None; Kaylie Webb-Jones, None; Dianna Wheaton, None; Kari Branham, None; Mohammad Othman, None; Athanasios Karoukis, None; Chris Andrews, None; John Heckenlively, None; David Birch, None; Stephen Daiger, None
  • Footnotes
    Support  2K12EY022299-06 NIH K12
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2961. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Abigail T Fahim, Lori S Sullivan, Sara J Bowne, Kaylie Webb-Jones, Dianna K.H. Wheaton, Kari E Branham, Mohammad Othman, Athanasios J Karoukis, Chris Andrews, John R Heckenlively, David G Birch, Stephen P Daiger; X-Chromosome Inactivation is a Biomarker of Clinical Severity in Female Carriers of X-linked Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2961.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : X-linked retinitis pigmentosa (XLRP) can manifest in female carriers with widely variable phenotypic severity, while others remain unaffected. The contribution of X-chromosome inactivation (XCI) to phenotypic variation has been postulated but not demonstrated. The purpose of this study is to describe the scope of clinical phenotype in female carriers with mutations in RPGR, and to quantify the contribution of XCI to phenotypic severity.

Methods : A cohort of 78 female carriers with RPGR mutations from 42 pedigrees with XLRP was ascertained. XCI ratios were determined in genomic DNA isolated from blood in 43 subjects and from saliva samples in 20 subjects, using methylation status of X-linked polymorphic repeats at the Androgen Receptor (AR) and RP2 loci. Clinical data included visual acuity (VA), Humphrey visual field (HVF), full field electroretinogram (ffERG), and dark adaptation (DA). Linear models were used to quantify the associations between XCI ratios and clinical parameters and severity.

Results : Visual acuity ranged from LogMAR -0.2 to 2.0 (Snellen 20/13 to 20/2000), with an average of LogMAR 0.27 (20/37). Horizontal visual field diameter using a size III spot ranged from 0 to 60 (maximum) degrees. ERG 30hz flicker ranged from barely recordable to normal, and scotopic rod ERG ranged from non-recordable to normal. Skewed XCI towards inactivation of the normal RPGR allele was associated with more severe disease. The XCI ratios in blood and saliva samples were highly correlated (r=0.96) and were both statistically significant predictors of visual function as measured by HVF diameter, rod amplitude, flicker amplitude, and flicker implicit time. Extreme XCI skewing of 80:20 or more was found in 4% of those with mild or no disease, 25% of those with moderate disease, and 57% of those with severe disease (p=0.002).

Conclusions : Female carriers with mutations in RPGR demonstrate widely variable clinical severity of retinal degeneration. XCI ratios in both blood and saliva correlate with clinical severity and may serve as a biomarker of clinically significant disease. As RPGR gene therapy trials are underway, there will be a future imperative to determine which carriers require intervention and when to intervene, and XCI analysis may be a useful measurement in determining suitable candidates for early intervention.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×